cannabidivarin   Click here for help

GtoPdb Ligand ID: 11092

Synonyms: CBDV | GWP42006
Compound class: Natural product or derivative
Comment: Cannabidivarin is a non-psychoactive phytocannabinoid found in plants of the Cannabis species.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 0
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 40.46
Molecular weight 286.19
XLogP 5.67
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CCCc1cc(O)c(c(c1)O)[C@H]1C=C(C)CC[C@@H]1C(=C)C
Isomeric SMILES CCCc1cc(O)c(c(c1)O)[C@H]1C=C(C)CC[C@@H]1C(=C)C
InChI InChI=1S/C19H26O2/c1-5-6-14-10-17(20)19(18(21)11-14)16-9-13(4)7-8-15(16)12(2)3/h9-11,15-16,20-21H,2,5-8H2,1,3-4H3/t15-,16+/m1/s1
InChI Key REOZWEGFPHTFEI-CVEARBPZSA-N
No information available.
Summary of Clinical Use Click here for help
Cannabidivarin (CBDV) is being investigated for clinical anticonvulsant (anti-epileptic) activity. It is also being evaluated for therapeutic benefit on communication, social interactions, sleep, behaviour, and cognition in people with autism spectrum disorder. In the EU CBDV has orphan designations for the treatment of Rett syndrome (2017) and fragile X syndrome (2018).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03849456 Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder Phase 2 Interventional GW Research Ltd
NCT02369471 A Study of GWP42006 in People With Focal Seizures - Part A Phase 2 Interventional GW Research Ltd
NCT02365610 A Study of GWP42006 in People With Focal Seizures - Part B Phase 2 Interventional GW Research Ltd